| Document Date: 2015-03-24 12:30:06
Open Document File Size: 45,38 KBShare Result on Facebook
Company Medicenna Therapeutics Inc. / / Country United States / / Event FDA Phase / / IndustryTerm drug manufacturing / Treatment of Cancer / / MedicalCondition cancers / brain cancers / Texas' cancer / Recurrent Glioblastoma / cancer / tumors / adult brain cancer / brain cancer / GBM tumors / Other Aggressive Cancers / glioblastoma multiforme / / Organization FDA / / Position Company Product Development Award Principal Investigator / / Product MDNA55 / / ProvinceOrState Texas / / Technology drug development / /
SocialTag |
Award ID: DP150031 Project Title: A Multi-Targeted Approach for Recurrent Glioblastoma and Other Aggressive Cancers: Exploiting the Potential of IL-4 Fusion Proteins Treatment of Cancer